Pain Management during Bromelain-Based Enzymatic Debridement (NexoBrid<sup>®</sup>) in a USA Adult Burn Center
Outside the United States, bromelain-based enzymatic debridement (BBED) has become an effective tool for the removal of burn eschar. A primary concern with BBED is that it is a painful procedure requiring appropriate analgesia. The purpose of this study was to describe our experience using NexoBrid&...
Saved in:
Main Authors: | Martin R. Buta (Author), Domenic Annand (Author), Sarah Findeisen (Author), Sean A. Hickey (Author), Robert L. Sheridan (Author), Jonathan S. Friedstat (Author), John T. Schulz (Author), Branko Bojovic (Author), Edward A. Bittner (Author), Jeremy Goverman (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Limitations to the use of bromelain-based enzymatic debridement (NexoBrid) for treating diabetic foot burns: a case series of disappointing results
by: Juan Enrique Berner, et al.
Published: (2018) -
Economic Spillovers from Public Medical Countermeasure Investments: A Case Study of NexoBrid®
by: F. Farahati, et al.
Published: (2017) -
Therapeutic management of the enzymatic debriding agent Nexobrid® in the burn patient
by: Enrique Salmeron-Gonzalez, et al.
Published: (2018) -
Successful treatment of mixed depth flame burns using enzymatic debridement with Nexobrid™ in a patient with aggressive systemic sclerosis (scleroderma)
by: Neil Wickham, et al.
Published: (2019) -
Papaya pulp for enzymatic wound debridement in burns
by: Rajshree C Jayarajan, et al.
Published: (2016)